日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Broadening SARS-CoV-2 Immunity by Combining ORFV and Protein-Based Vaccines.

通过结合 ORFV 和蛋白质疫苗来扩大 SARS-CoV-2 免疫力。

Reguzova Alena, Müller Melanie, Fandrich Madeleine, Dulovic Alex, Amann Ralf

First-in-Human Phase I Trial to Assess the Safety and Immunogenicity of an Orf Virus-Based COVID-19 Vaccine Booster.

首次人体 I 期试验,评估基于羊痘病毒的 COVID-19 疫苗加强针的安全性和免疫原性

Esen Meral, Fischer-Herr Johanna, Gabor Julian Justin, Gaile Johanna Marika, Fleischmann Wim Alexander, Smeenk Geerten Willem, de Moraes Roberta Allgayer, Bélard Sabine, Calle Carlos Lamsfus, Woldearegai Tamirat Gebru, Egger-Adam Diane, Haug Verena, Metz Carina, Reguzova Alena, Löffler Markus W, Balode Baiba, Matthies Lars C, Ramharter Michael, Amann Ralf, Kremsner Peter G

Orf Virus-Based Vectors Preferentially Target Professional Antigen-Presenting Cells, Activate the STING Pathway and Induce Strong Antigen-Specific T Cell Responses.

基于羊痘病毒的载体优先靶向专业抗原呈递细胞,激活 STING 通路,并诱导强烈的抗原特异性 T 细胞反应

Müller Melanie, Reguzova Alena, Löffler Markus W, Amann Ralf

A Novel Orf Virus D1701-VrV-Based Dengue Virus (DENV) Vaccine Candidate Expressing HLA-Specific T Cell Epitopes: A Proof-of-Concept Study.

一种基于新型羊痘病毒D1701-VrV的登革病毒(DENV)候选疫苗,表达HLA特异性T细胞表位:概念验证研究

Reguzova Alena, Fischer Nico, Müller Melanie, Salomon Ferdinand, Jaenisch Thomas, Amann Ralf

Design and evaluation of optimized artificial HIV-1 poly-T cell-epitope immunogens

优化人工HIV-1多聚T细胞表位免疫原的设计与评价

Reguzova, Alena; Antonets, Denis; Karpenko, Larisa; Ilyichev, Alexander; Maksyutov, Rinat; Bazhan, Sergei